アレルギー性鼻炎治療薬の世界市場:治験レビュー

◆英語タイトル:Allergic Rhinitis Global Clinical Trials Review, H2, 2019
◆商品コード:GDT20FB0058
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:897
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Allergic Rhinitis Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H2, 2019 provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Allergic Rhinitis to Respiratory Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Allergic Rhinitis to Respiratory Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Allergic Rhinitis Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Allergic Rhinitis 37
Nov 26, 2019: Marinomed Biotech AG: Detailed clinical data show rapid onset of action of Budesolv to alleviate hay fever 37
Nov 08, 2019: ALK to present new phase 3 data demonstrating the efficacy and safety of Ragwitek (short ragweed pollen allergen extract tablet for sublingual use 12 Amb a 1-U) Sublingual Allergy Immunotherapy (SLIT)-Tablets in pediatric patients at ACAAI 2019 Annual Scientific Meeting 37
Clinical Trial Profile Snapshots 39
Appendix 926
Abbreviations 926
Definitions 926
Research Methodology 927
Secondary Research 927
About GlobalData 928
Contact Us 928
Source 929

List of Tables
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2019* 8
Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2019* 17
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2019* 21
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2019* 25
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 26
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29
Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30
Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 31
Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36

List of Figures
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2019* 17
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2019* 21
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 25
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 26
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29
Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30
Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 31
Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36
GlobalData Methodology 927

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アレルギー性鼻炎治療薬の世界市場:治験レビュー]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆